OptimizeRx (OPRX) Accumulated Expenses (2010 - 2026)

OptimizeRx has disclosed Accumulated Expenses across 17 years of filings, most recently posting $5.4 million for Q2 2026.

• In Q2 2026, Accumulated Expenses fell 56.86% year-over-year to $5.4 million; the TTM figure through Jun 2026 stood at $5.4 million (down 56.86% YoY), while the FY2025 annual figure was $11.6 million, up 36.59% from the prior year.
• Accumulated Expenses came in at $5.4 million for Q2 2026 at OptimizeRx, up from $3.6 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $12.5 million in Q2 2025 to a low of $1.5 million in Q2 2023.
• Average Accumulated Expenses over 5 years is $5.6 million, with a median of $5.3 million recorded in 2024.
• Year-over-year, Accumulated Expenses soared 253.18% in 2024 and slumped 61.28% in 2026.
• Over 5 years, Accumulated Expenses stood at $2.6 million in 2022, then soared by 196.24% to $7.7 million in 2023, then grew by 10.12% to $8.5 million in 2024, then surged by 36.59% to $11.6 million in 2025, then plunged by 53.51% to $5.4 million in 2026.
• Per Business Quant data, the three most recent Accumulated Expenses figures were $5.4 million in Q2 2026, $3.6 million in Q1 2026, and $11.6 million in Q4 2025.